Tenaya Therapeutics/$TNYA
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Tenaya Therapeutics
Tenaya Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of therapies targeting the underlying mechanisms of heart disease. It is developing therapies for rare genetic disorders as well as for more prevalent heart conditions through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. The company's clinical-stage gene therapy candidates include TN-201 and TN-401. It operates in one operating segment, which is the business of discovering and developing potential treatments that address the underlying drivers of heart disease.
Ticker
$TNYA
Sector
Primary listing
Employees
70
Headquarters
Website
TNYA Metrics
BasicAdvanced
$163M
-
-$0.59
3.22
-
Price and volume
Market cap
$163M
Beta
3.22
52-week high
$2.35
52-week low
$0.36
Average daily volume
5.3M
Financial strength
Current ratio
6.84
Quick ratio
6.514
Long term debt to equity
6.336
Total debt to equity
8.786
Profitability
EBITDA (TTM)
-84.895
Management effectiveness
Return on assets (TTM)
-43.72%
Return on equity (TTM)
-83.84%
Valuation
Price to book
1.32
Price to tangible book (TTM)
1.32
Price to free cash flow (TTM)
-1.668
Free cash flow yield (TTM)
-59.94%
Free cash flow per share (TTM)
-0.45
Growth
Earnings per share change (TTM)
-54.80%
3-year earnings per share growth (CAGR)
-40.12%
What the Analysts think about TNYA
Analyst ratings (Buy, Hold, Sell) for Tenaya Therapeutics stock.
TNYA Financial Performance
Revenues and expenses
TNYA Earnings Performance
Company profitability
TNYA News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Tenaya Therapeutics stock?
Tenaya Therapeutics (TNYA) has a market cap of $163M as of March 23, 2026.
What is the P/E ratio for Tenaya Therapeutics stock?
The price to earnings (P/E) ratio for Tenaya Therapeutics (TNYA) stock is 0 as of March 23, 2026.
Does Tenaya Therapeutics stock pay dividends?
No, Tenaya Therapeutics (TNYA) stock does not pay dividends to its shareholders as of March 23, 2026.
When is the next Tenaya Therapeutics dividend payment date?
Tenaya Therapeutics (TNYA) stock does not pay dividends to its shareholders.
What is the beta indicator for Tenaya Therapeutics?
Tenaya Therapeutics (TNYA) has a beta rating of 3.22. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.